GWAS, which scan the genomes of thousands of people for known genetic variants in the form of single nucleotide polymorphisms, have proven highly successful in identifying variants associated with susceptibility to chronic diseases such as Alzheimer's disease, type 2 diabetes and macular degeneration [7,8].